Long-term follow-up of the RTOG 9501/intergroup phase III trial: Postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 5, 2012, Pages 1198-1205

  Cooper, Jay S ^a   Zhang, Qiang ^b   Pajak, Thomas F ^b   Forastiere, Arlene A ^c   Jacobs, John ^d   Saxman, Scott B ^e   Kish, Julie A ^f   Kim, Harold E ^d   Cmelak, Anthony J ^g   Rotman, Marvin ^h   Lustig, Robert ⁱ   Ensley, John F ^d   Thorstad, Wade ^j   Schultz, Christopher J ^k   Yom, Sue S ^l   Ang, K Kian ^m  

^a Maimonides Cancer Center   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^g VANDERBILT INGRAM CANCER CENTER   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^j WASHINGTON UNIVERSITY   (United States)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIS-PLATIN; CONCURRENT RADIATION THERAPY; DISEASE FREE SURVIVAL; FAILURE RATE; HEAD-AND-NECK CANCER; LONG-TERM FOLLOW-UP; LONG-TERM OUTCOME; LYMPH NODE; OVERALL SURVIVAL; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECKS;

CHEMOTHERAPY; DISEASE CONTROL; PATIENT MONITORING; PLATINUM COMPOUNDS; RADIOTHERAPY;

CONCURRENCY CONTROL;

CISPLATIN;

ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG FATALITY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MICROSCOPY; NEPHROTOXICITY; NEUROTOXICITY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SKIN TOXICITY; STATISTICAL SIGNIFICANCE; TOXICITY; TREATMENT FAILURE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; SMOKING; TIME FACTORS;

EID: 84869139611     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.05.008     Document Type: Article

References (18)

1. J.S. Cooper, T.F. Pajak, and A. Forastierre Precisely defining high-risk operable head-and-neck tumors based on RTOG #85-03 and #88-24: targets for post-operative radiochemotherapy Head Neck 20 1998 588 594
2. M. Morris, P.J. Eifel, and J. Lu Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143
3. J.S. Cooper, M. Guo, and A. Herskovic Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized Intergroup trial (RTOG 85-01) JAMA 281 1999 1623 1627
4. M. Al-Sarraf, M. LeBlanc, and P.G. Shanker Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099 J Clin Oncol 16 1998 1310 1317
5. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx Carcinoma J Natl Cancer Inst 91 1999 2081 2086
6. D.J. Adelstein, P. Lavertu, and J.P. Saxton Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck Cancer 88 2000 876 883
7. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804
8. J.S. Cooper, T.F. Pajak, A.A. Forastiere Radiation Therapy Oncology Group 9501/Intergroup Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
9. J. Bernier, C. Domenge, M. Ozsahin European Organization for Research and Treatment of Cancer Trial 22931 Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952
10. M. Zelen The randomization and stratification of patients to clinical trials J Chron Dis 27 1974 365 375
11. Early Breast Cancer Trialists' Collaborative Group Effects of radiotherapy and surgery in early breast cancer: an overview of randomized trials N Engl J Med 333 1995 1444 1455
12. J.D. Kalbfleisch, and R.L. Prentice The statistical analysis of failure time data 1980 Wiley New York
13. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
14. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457
15. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chem Rep 5 1966 163 170
16. D.R. Cox Regression models and life tables J Royal Stat Soc (series B) 34 1972 187 229
17. D. Rubin Multiple imputations for nonresponse in surveys 1987 Wiley New York
18. J. Bernier, J.S. Cooper, and T.F. Pajak Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck 27 2005 843 850